SCHEMBL7868065

SCHEMBL7868065

NC(=O)c1csc(NC(=O)[CH]CCCNC(=O)OCc2ccccc2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.48
HTT P42858 1/20 0.48
TGM2 P21980 1/20 0.47
HDAC6 Q9UBN7 3/20 0.44
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KEAP1 Q14145 2/20 0.41
NFE2L2 Q16236 2/20 0.41
FOLH1 Q04609 5/20 0.41
HDAC3 O15379 2/20 0.41
HDAC4 P56524 2/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC7 Q8WUI4 2/20 0.41
HDAC2 Q92769 2/20 0.41
HDAC10 Q969S8 2/20 0.41
HDAC11 Q96DB2 2/20 0.41
HDAC8 Q9BY41 2/20 0.41
HDAC9 Q9UKV0 2/20 0.41
HDAC5 Q9UQL6 2/20 0.41
ANPEP P15144 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7868121 0.97 MAPK1 (0.50) MAPK1HTTTGM2HDAC6LMNA
SCHEMBL5057159 0.85 MAPK1 (0.39) MAPK1TGM2HDAC6LMNASMN1; SMN2
SCHEMBL7873367 0.79 TGM2 (0.49) MAPK1HTTTGM2LMNASMN1; SMN2
SCHEMBL7874778 0.77 HDAC3 (0.48) HDAC6LMNASMN1; SMN2HDAC3HDAC4
SCHEMBL7873416 0.73 ANPEP (0.49) HTTTGM2LMNASMN1; SMN2KEAP1
SCHEMBL6056911 0.73 PDE5A (0.46) HTTHDAC6LMNASMN1; SMN2HDAC3
SCHEMBL8698925 0.71 HTT (0.80) HTTTGM2HDAC6LMNASMN1; SMN2
SCHEMBL7976783 0.70 TGM2 (0.65) HTTTGM2LMNASMN1; SMN2KEAP1
SCHEMBL11310879 0.70 MAPK1 (0.49) MAPK1HDAC6SMN1; SMN2HDAC3HDAC4
SCHEMBL735886 0.70 HTT (0.68) HTTTGM2LMNASMN1; SMN2KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329400-B1 INHIBITION OR ANTAGONISM OF MATRIX METALLOPROTEASES, AND/OR TUMOR NECROSIS FACTOR-ALPHA; EXTRACELLULAR MATRIX DEGRADATION, INHIBITION OF SHEDDING OF CELL SURFACE PROTEIN ECTODOMAINS AND CD23 PROTEOLYSIS GLAXO WELLCOME INC. 2001-12-11 US disclosed